Psyence Group Information

Psyence (PSYG) is a clinical-stage life science biotechnology company pioneering the use of natural psilocybin in mental health and well‑being. We have a focus on these conditions in the context of palliative care. Psyence is listed on the Canadian Stock Exchange (CSE: PSYG) and on the US OTCQB® Venture Market (OTCQB: PSYGF). Our diversified business has a global footprint with operations in multiple legal jurisdictions. We operate one of the first federally licensed commercial psilocybin cultivation and production facilities in the world in Southern Africa. For more information: www.psyence.com

Website	https://www.psyence.com/
Employees	7 (4 on RocketReach)
Founded	2019
Address	200 Bay Street, Suite 210, Toronto, Ontario M5J 2J1, CA
Industry	Biotechnology Research
Keywords	Psychedelic Medicine, Psilocybin Therapy, Palliative Care, Psilocybin Research, Clinical Trials, Mental Health Treatment, Clinical Stage Biotech, Mental Wellness, Innovative Therapies, Wellbeing Solutions, Mycotherapy, New Treatments, Life Science Research, Drug Development, Biotechnology, Integrative Healthcare, Alternative Medicine
Competitors	COMPASS Pathways, MindMed, Field Trip Health, Cybin Inc, HAVN Life, Delix Therapeutics, Silo Wellness (CSE: SILO) (OTC: SILFF) - Psychedelic Retreats - Jamaica Oregon, Revive Therapeutics Ltd. CSE: RVV \| USA: RVVTF, Mydecine Innovations Group, Quantum 9, Inc. +28 more (view full list)